Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Tohoku University divulges dioxolan derivatives for renal diseases

Sep. 2, 2020

Ardelyx divulges glycyrrhetinic derivatives for hyperkalemia

Sep. 1, 2020

Taisho Pharmaceutical discloses new 20-HETE synthase inhibitors

Aug. 31, 2020

Evotec and Novo Nordisk collaborate to develop novel therapies for CKD

Aug. 19, 2020

AstraZeneca is enrolling participants in phase I study of MEDI-8367

Aug. 7, 2020

Positive topline data presented from phase IIa ACTION study of DMX-200 in FSGS

July 30, 2020

Phase III DAPA-CKD trial of Farxiga meets all primary and secondary endpoints

July 28, 2020

Metabolic reprogramming promotes ADPKD cystogenesis

July 22, 2020

Goldfinch Bio begins phase IIa study of GFB-887 for renal diseases

July 21, 2020

Apolipoprotein L1 inhibitors discovered at Vertex Pharmaceuticals

July 15, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Sun Pharma to acquire Merck spinoff Organon for $11.75B
BioWorld
Sun Pharmaceuticals Industries Ltd. will pay $11.75 billion cash to acquire Organon & Co. The transaction is expected to close in early 2027. The addition of...